- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04616508
Online Motor Control in People With Parkinson's Disease
October 30, 2020 updated by: University of Delaware
This study aims to better understand how people with Parkinson's control reaching movements.
Specifically, we are asking how these individuals respond to different environmental perturbations.
Testing includes reaching movements made within a virtual reality set-up.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting approximately up to 10 million people worldwide and with 60,000 new cases diagnosed annually in the U.S. alone.
Some of the most common signs and symptoms in individuals with PD are slowed and small movements and difficulty in movement initiation.
The ability to correct movements online in response to environmental changes is an important part of daily living.
Online movement corrections in reaching refer to the ability to smoothly change how and where you reach in response to a change in the environment.
For example, one can adjust the position of the hand and arm when trying to catch a butterfly flying in the air.
Generally speaking, online movement corrections can happen in response to visual perturbations (e.g., trying to catch a butterfly) or to force perturbations (e.g., someone knocks your hand while you're holding a coffee mug).
Since individuals with PD have trouble with movements, it stands to reason that they may have problems with online movement corrections.
Surprisingly, very little is known about online movement corrections in individuals with PD.
The current evidence suggests that individuals with PD can make online movement corrections to small visual perturbations, but whether they can successfully respond to large visual perturbations is debatable.
Furthermore, whether individuals with PD can make online movement corrections to force perturbations has not been studied.
The aim of this project is to investigate if individuals with PD can make online movement corrections during reaching to visual and/or force perturbations.
We will test both individuals with PD and age-matched healthy controls.
They will perform reaching movements while visual or force perturbations are applied.
We will use various perturbation strengths in order to test for potential differences in responses to small and large perturbations.
Results from this study will provide new information on how individuals with PD make online movement corrections, and possibly provide insight to improving rehabilitation for PD.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hyosub Kim, PhD
- Phone Number: 302-831-4263
- Email: hyosub@udel.edu
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Recruiting
- University of Delaware
-
Contact:
- Joie Tang
-
Principal Investigator:
- Hyosub Kim, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria (all participants):
- Age 18-85 years
- Able to perform reaching movements of ~20 cm (8 inches)
- MMSE score ≥ 26/30
- Willing and able to attend all testing sessions
Inclusion criteria (PD group only):
- Diagnosis of idiopathic Parkinson's disease per self report
- Currently taking dopaminergic/dopamine agonist medication
Exclusion criteria (all participants):
- Any chronic or recent upper extremity musculoskeletal conditions that affects reaching
- Any neurological disorders other than Parkinson's disease (e.g., seizure disorders, closed head injuries with loss of consciousness greater than 15 minutes, CNS neoplasm, history of stroke)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Behavioral testing
|
Basic science study of control of reaching movements
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
End-point errors
Time Frame: during intervention
|
Euclidean distance from target to final hand position (units: cm); measurement derived from position data sampled at 1000 Hz
|
during intervention
|
Reaction times
Time Frame: during intervention
|
Time from visual target presentation to movement onset (units: ms); measurement derived from position data sampled at 1000 Hz
|
during intervention
|
Movement times
Time Frame: during intervention
|
Time from movement onset to movement end (units: ms); measurement derived from position data sampled at 1000 Hz
|
during intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Hyosub Kim, PhD, University of Delaware
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 12, 2018
Primary Completion (Anticipated)
December 12, 2024
Study Completion (Anticipated)
December 12, 2026
Study Registration Dates
First Submitted
October 23, 2020
First Submitted That Met QC Criteria
October 30, 2020
First Posted (Actual)
November 5, 2020
Study Record Updates
Last Update Posted (Actual)
November 5, 2020
Last Update Submitted That Met QC Criteria
October 30, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1358328-5
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on motor control assessment
-
Afyonkarahisar Health Sciences UniversityRecruiting
-
Centre d'Investigation Clinique et Technologique...CompletedSpinal Muscular Atrophy | Assessment, SelfFrance
-
National Research Center for Rehabilitation Technical...RecruitingDysphagia | Healthy Volunteers | Motor DeficitsChina
-
Peking University Third HospitalCompletedCervical Spine MyelopathyChina
-
Helsinki University Central HospitalUniversity of Helsinki; Tampere University; Kamuzu University of Health SciencesRecruitingInfant DevelopmentFinland, Malawi
-
Cliniques universitaires Saint-Luc- Université...UnknownCerebral Palsy | Perceptual Disorders | HemiparesisBelgium
-
Gazi UniversityCompleted
-
Great Lakes NeuroTechnologies Inc.National Institute of Nursing Research (NINR)Unknown
-
Riphah International UniversityCompletedPostural ControlPakistan